Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edith A. Perez, MD
Mayo Clinic
Study Chair - Kathy Miller, MD
Indiana University
Study Chair - Melody A. Cobleigh, MD
Rush University Medical Center
Study Chair - Robin Zon, MD
Elkhart General Hospital
- Tamara N. Shenkier, MD
British Columbia Cancer Agency
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- British Columbia Cancer Agency
Vancouver, British Columbia, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Mbccop - Gulf Coast
Mobile, Alabama, United States
- Ccop - Mayo Clinic Scottsdale Oncology Program
Scottsdale, Arizona, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- Siouxland Hematology-Oncology
Sioux City, Iowa, United States
- Ccop - Ochsner
New Orleans, Louisiana, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- Ccop - Duluth
Duluth, Minnesota, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Centracare Health Plaza
Saint Cloud, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Medcenter One Health System
Bismarck, North Dakota, United States
- Ccop - Merit Care Hospital
Fargo, North Dakota, United States
- Altru Cancer Center
Grand Forks, North Dakota, United States
- Ccop - Dayton
Dayton, Ohio, United States
- Ccop - Toledo Community Hospital
Toledo, Ohio, United States
- Ccop - Oklahoma
Tulsa, Oklahoma, United States
- Ccop - Geisinger Clinic and Medical Center
Danville, Pennsylvania, United States
- Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
- Ccop - Upstate Carolina
Spartanburg, South Carolina, United States
- Rapid City Regional Hospital
Rapid City, South Dakota, United States
- Ccop - Sioux Community Cancer Consortium
Sioux Falls, South Dakota, United States
- Ccop - St. Vincent Hospital Cancer Center, Green Bay
Green Bay, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jan 2002
- Primary completion
- 30 Nov 2006
- Completion
- 31 May 2009
- Last update posted
- 15 Jun 2023
- Registered enrollment
- 722
- Registry id
- NCT00028990
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.